首页> 外文会议>Annual technical conference of the Society of Plastics Engineers;ANTEC 2011 >Melt Extrusion for the Enablement of Pharmaceutical Products - Case Study Using Griseofulvin
【24h】

Melt Extrusion for the Enablement of Pharmaceutical Products - Case Study Using Griseofulvin

机译:用于药物产品的熔融挤出-使用灰黄霉素的案例研究

获取原文

摘要

Melt extrusion has gained significant interest in the pharmaceutical industry due to the continuous nature and ability to provide unique dosage form characteristics. Enhancement of oral bioavailability to enable drug products has been exploited extensively using melt extrusion. In this study melt extrusion was used for the preparation of griseofulvin solid dispersions. Using this technology amorphous formulations of drug and non-ionic polymers were prepared. Compositions were evaluated for physical characteristics, chemical performance and dissolution rate. Results showed that all formulations could be prepared below the melting temperature of the drug substance and the resulting formulations provided significant levels of supersaturation during dissolution testing.
机译:由于连续的性质和提供独特剂型特征的能力,熔体挤出在制药工业中引起了极大的兴趣。使用熔体挤出已经广泛地利用了提高口服生物利用度以使药物成为可能。在这项研究中,熔融挤出用于制备灰黄霉素的固体分散体。使用该技术,制备了药物和非离子聚合物的无定形制剂。评价组合物的物理特性,化学性能和溶解速率。结果表明,可以在原料药的熔化温度以下制备所有制剂,并且所得制剂在溶出度测试期间提供了显着水平的过饱和。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号